首页> 外文期刊>Journal of clinical apheresis. >A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
【24h】

A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.

机译:一家三级医疗机构对血小板减少的捐赠者延期模式进行了为期3年的分析:在印度的情况下评估当前的捐赠者选择标准。

获取原文
获取原文并翻译 | 示例
       

摘要

INTRODUCTION: This study reports the frequency and nature of plateletpheresis deferrals and evaluates donors with low platelet count and hemoglobin levels so as to assess the possibility of reentry without hampering donor safety. MATERIALS AND METHODS: Three-year retrospective data of plateletpheresis deferral was collected. Data from actual procedures was also reviewed to analyze the safety of performing plateletpheresis in donors with low hemoglobin and platelet values. RESULTS: Four hundred sixteen donors were deferred for various reasons among 1,515 screened (27.5%), of which 69.7% deferrals were because of low platelet count (55.8%) and less hemoglobin levels. Among the low platelet count donor group, 20.3% had a count between 141 and 149 x 10(9)/L and 41.8% below 120 x 10(9)/L. Of the 14% donors deferred for low hemoglobin, 62.1% had values in the range of 11.5-12.4 g/dL with normal mean corpuscular volume and red cell distribution width in most (86.2%) of them. Expected blood loss in each procedure varied between 20 and 30 mL, whereas RBC contamination in the product varied from 0 to 1.6 mL in 538 procedures. There were 176 donations with predonation platelet count <180 x 10(9)/L (32.7%). None of the 14 procedures performed on donors with platelet count of 150 x 10(9)/L showed evidence of thrombocytopenia or donor reaction. CONCLUSION: Lowering the cut-off value for plateletpheresis from 12.5 g/dL to 11.5 g/dL has no deleterious effect on donor safety as the blood loss is minimal. One-fifth deferrals can be reconsidered if the criteria of plateletpheresis donor selection are relaxed for hemoglobin and platelet count.
机译:简介:本研究报告了血小板减少症延期的频率和性质,并评估了血小板计数和血红蛋白水平较低的供体,以评估再次入院的可能性,而不会影响供体的安全性。材料与方法:收集三年的血小板减少症回顾性数据。还审查了来自实际程序的数据,以分析在血红蛋白和血小板值低的供体中进行血小板减少的安全性。结果:在因筛查的1515人中,有416位捐赠者因各种原因而被推迟(占27.5%),其中69.7%的推迟是由于血小板计数低(55.8%)和血红蛋白水平降低。在低血小板计数供体组中,20.3%的计数在141至149 x 10(9)/ L之间,而在120 x 10(9)/ L以下则为41.8%。在延缓低血红蛋白的14%供体中,有62.1%的值在11.5-12.4 g / dL范围内,其中大多数(86.2%)的平均红细胞体积和红细胞分布宽度正常。每个程序的预期失血量在20到30 mL之间,而在538个程序中产品中的RBC污染从0到1.6 mL不等。有176次捐赠,其捐赠前血小板计数<180 x 10(9)/ L(32.7%)。在血小板计数为150 x 10(9)/ L的供体上执行的14个步骤中,没有一个显示出血小板减少或供体反应的迹象。结论:将血小板减少的临界值从12.5 g / dL降低到11.5 g / dL不会对献血者的安全产生有害影响,因为失血量很小。如果放宽血红蛋白和血小板计数的血小板供体供体选择标准,可以考虑五分之一的延期。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号